Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant. [electronic resource]
Producer: 20111031Description: 1239-48 p. digitalISSN:- 1029-2403
- Adolescent
- Adult
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Middle Aged
- Models, Statistical
- Quality of Life
- Rituximab
- Surveys and Questionnaires
- Time Factors
- Transplantation, Autologous
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.